AMERICAN REBEL HOLDINGS INC (AREB)

US02919L3078 - Common Stock

1.67  +0.03 (+1.83%)

After market: 1.66 -0.01 (-0.6%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to AREB. AREB was compared to 83 industry peers in the Commercial Services & Supplies industry. AREB may be in some trouble as it scores bad on both profitability and health. AREB does not seem to be growing, but still is valued expensively.



0

1. Profitability

1.1 Basic Checks

AREB had negative earnings in the past year.
AREB had a negative operating cash flow in the past year.
In the past 5 years AREB always reported negative net income.
AREB had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of -138.55%, AREB is doing worse than 97.59% of the companies in the same industry.
The Return On Equity of AREB (-723.82%) is worse than 91.57% of its industry peers.
Industry RankSector Rank
ROA -138.55%
ROE -723.82%
ROIC N/A
ROA(3y)-249.25%
ROA(5y)-337.62%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

AREB's Gross Margin of 10.42% is on the low side compared to the rest of the industry. AREB is outperformed by 84.34% of its industry peers.
AREB's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for AREB so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 10.42%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.72%
GM growth 5Y-21.19%

0

2. Health

2.1 Basic Checks

AREB does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for AREB has been increased compared to 1 year ago.
AREB has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, AREB has a worse debt to assets ratio.

2.2 Solvency

AREB has an Altman-Z score of -7.55. This is a bad value and indicates that AREB is not financially healthy and even has some risk of bankruptcy.
AREB has a Altman-Z score of -7.55. This is amonst the worse of the industry: AREB underperforms 92.77% of its industry peers.
AREB has a Debt/Equity ratio of 2.57. This is a high value indicating a heavy dependency on external financing.
AREB has a worse Debt to Equity ratio (2.57) than 84.34% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.57
Debt/FCF N/A
Altman-Z -7.55
ROIC/WACCN/A
WACC14.01%

2.3 Liquidity

AREB has a Current Ratio of 0.93. This is a bad value and indicates that AREB is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.93, AREB is not doing good in the industry: 79.52% of the companies in the same industry are doing better.
AREB has a Quick Ratio of 0.93. This is a bad value and indicates that AREB is not financially healthy enough and could expect problems in meeting its short term obligations.
AREB has a worse Quick ratio (0.28) than 95.18% of its industry peers.
Industry RankSector Rank
Current Ratio 0.93
Quick Ratio 0.28

2

3. Growth

3.1 Past

AREB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -69.60%.
Looking at the last year, AREB shows a decrease in Revenue. The Revenue has decreased by -3.53% in the last year.
AREB shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 162.58% yearly.
EPS 1Y (TTM)-69.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-824.2%
Revenue 1Y (TTM)-3.53%
Revenue growth 3Y134.41%
Revenue growth 5Y162.58%
Sales Q2Q%-11.3%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y266.67%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year21.58%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AREB. In the last year negative earnings were reported.
AREB is valuated correctly with a Price/Forward Earnings ratio of 14.88.
Compared to the rest of the industry, the Price/Forward Earnings ratio of AREB indicates a rather cheap valuation: AREB is cheaper than 80.72% of the companies listed in the same industry.
AREB is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.83, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 14.88

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

AREB's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

AREB does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

AMERICAN REBEL HOLDINGS INC

NASDAQ:AREB (12/20/2024, 8:00:00 PM)

After market: 1.66 -0.01 (-0.6%)

1.67

+0.03 (+1.83%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)11-21 2024-11-21
Earnings (Next)N/A N/A
Inst Owners2.46%
Inst Owner Change336.31%
Ins Owners1.09%
Ins Owner Change0%
Market Cap1.80M
Analysts82.86
Price TargetN/A
Short Float %3.22%
Short Ratio0.04
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 14.88
P/S 0.12
P/FCF N/A
P/OCF N/A
P/B 0.72
P/tB 3.47
EV/EBITDA N/A
EPS(TTM)-19.3
EYN/A
EPS(NY)0.11
Fwd EY6.72%
FCF(TTM)-7.66
FCFYN/A
OCF(TTM)-7.65
OCFYN/A
SpS14.31
BVpS2.33
TBVpS0.48
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -138.55%
ROE -723.82%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 10.42%
FCFM N/A
ROA(3y)-249.25%
ROA(5y)-337.62%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.72%
GM growth 5Y-21.19%
F-Score3
Asset Turnover1.17
Health
Industry RankSector Rank
Debt/Equity 2.57
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.93
Quick Ratio 0.28
Altman-Z -7.55
F-Score3
WACC14.01%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.09%
Cap/Sales(5y)0.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-69.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-824.2%
EPS Next Y266.67%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-3.53%
Revenue growth 3Y134.41%
Revenue growth 5Y162.58%
Sales Q2Q%-11.3%
Revenue Next Year21.58%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-188.91%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year212.46%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-89.37%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-89.52%
OCF growth 3YN/A
OCF growth 5YN/A